A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma

Clinical trial NCT00431912 · COMPLETED

Trial details

NCT number: NCT00431912
Sponsor: Valerio Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma

Start date: 2007-02-01
Primary completion: 2011-01-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.